Marion Blakey is the president and CEO of Rolls-Royce North America.(C)2012 RICHARD A BLOOM

This article is from the archive of our partner National Journal

CORPORATE LIFE

Marion Blakey

Rolls-Royce North America

) Marion Blakey is the president and CEO of Rolls-Royce North America. (Chet Susslin)Marion Blakey spent more than seven years as president and CEO of the Aerospace Industries Association, an Arlington, Virginia"“based defense manufacturers' trade group, before which she served in half a dozen positions in the federal government, including chairman of the National Transportation Safety Board and head of the Federal Aviation Administration. In May, Blakey, 67, took that wealth of insider experience to the private sector, becoming the first woman president and CEO of Rolls-Royce North America. Not to be confused with the car company Rolls-Royce Motor Cars, this subsidiary of the British multinational public-holding company oversees Rolls-Royce businesses across North America that specialize in aeroengines for civil and defense aircraft. As CEO, the Tupelo, Mississippi, native will "analyze and assess what opportunities are coming up" within the industry, which includes understanding and anticipating "what kinds of technology will be required to address the threats we'll have."

CONSULTING GAME

Sarah Landry

The Conafay Group

Sarah Landry is a consultant with The Conafay Group. (Chet Susslin)Last month, Sarah Landry joined The Conafay Group, a government-relations firm that works primarily with businesses involved in biomedical product development. In her new role as a consultant, Landry's job includes helping clients obtain funding to further develop products such as vaccines and drugs, and aiding them in forging public-private partnerships that support both their work and government priorities. Landry came to the firm from the Food and Drug Administration's Center for Tobacco Products, where for three years she was a senior policy analyst. But it was likely her previous job — as a senior adviser for the Health and Human Services Department's National Vaccine Program Office — that best prepared her for her current role. There, the 50-year-old from Madison, Wisconsin, helped the office coordinate immunization activities across federal agencies and aided in prevention efforts around everything from bioterrorism to the pandemic flu.

INTEREST GROUPS

Barbara Nussbaum

The American Society of Health-System Pharmacists' Research and Education Foundation

Barbara Nussbaum is the vice president of the American Society of Health-System Pharmacists' Research and Education Foundation. (Chet Susslin)On April 6, Barbara Nussbaum, 50, was named vice president of the American Society of Health-System Pharmacists' Research and Education Foundation, the philanthropic arm of ASHP — the professional organization that represents the interests of pharmacists. A pharmacist by training herself, Nussbaum was previously the director of adult learning and educational programs in ASHP's educational-services division. (The Rockville, Maryland, native has a doctorate in adult learning and human-resource development from Virginia Tech. "I am not somebody just to wing things," she tells me.) In her new capacity, Nussbaum will oversee all the foundation's programs — a job that includes everything from working with the board of directors to identify the best uses of research grant money, to expanding ASHP's educational offerings. While she loved her old job, she says, she was ready to have an impact on what pharmacists do "at a deeper level." 

This article is from the archive of our partner National Journal.

We want to hear what you think about this article. Submit a letter to the editor or write to letters@theatlantic.com.